Iambic Therapeutics annual operating margin
2024
2025
Iambic Therapeutics's operating margin was −873.65% for fiscal 2025.
View full Iambic Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −873.65% | +3638.66 pp |
| 2024 | 2024-12-31 | −4,512.31% | — |
Between the periods ended 2024-12-31 and 2025-12-31, Iambic Therapeutics's operating margin increased from −4,512.31% to −873.65%, a change of +3638.66 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Iambic Therapeutics source filings ↗